Skip to content

Operating margin at other companies

IAR
Integra LifeSciencesIART
-29.8%-30.3pp
MiMedx Group logo
MiMedx GroupMDXG
10.2%-5.1pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-5.8%-2.1pp
Bioventus logo
BioventusBVS
10%
Artivion logo
ArtivionAORT
8.2%+4.1pp
Axogen logo
AxogenAXGN
-3.8%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Based on trailing twelve months.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s operating margin?
Organogenesis Holdings Inc. (ORGO) reported operating margin of 0.5% in Q1 2026.
What is the long-term trend for Organogenesis Holdings Inc.'s operating margin?
Over 3 years (2020 to 2025), Organogenesis Holdings Inc.'s operating margin has grown at a -0.3% compound annual growth rate (CAGR), from 8% to 7.9%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.